Literature DB >> 15456825

Abl tyrosine kinase promotes dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho family small GTPases in hippocampal neurons.

Shiloh B Jones1, Hope Y Lu, Qun Lu.   

Abstract

Nonreceptor tyrosine kinase Abl is an actin-binding protein and a key regulator of neuronal axonal development. Although Abl family kinases also are localized in dendrites and are implicated in postsynaptic functions, it is not clear how Abl kinases regulate dendritic morphogenesis. Using a developing hippocampal culture as a model, we found that the inhibition of Abl kinases by STI571 leads to a remarkable simplification of dendritic branching similar to the phenotype caused by an increased activity of small GTPase RhoA. Time-lapse microscopic imaging reveals a prominent reduction of dendritic branching. In contrast, neurons expressing a constitutively active v-abl construct (CA-Abl) show an exuberant microtubule-associated protein 2-positive (MAP2-positive) dendrite outgrowth, suggesting that Abl modulates dendritic growth. Biochemical assays using a glutathione S-transferase pull-down method to determine GTP-bound active Rho GTPases demonstrate that Abl inhibition increases RhoA activity but has no effect on the activity of Rac1 or Cdc42. At the cellular level the alteration of Abl also changes actin organization consistent with RhoA inhibition. Suppression of the RhoA downstream effector Rho kinase reverses STI571-induced dendritic simplification, demonstrating that activity of the Rho pathway is responsible for the Abl-induced changes in dendrogenesis. Furthermore, CA-Abl-induced neurite outgrowth is blocked by the expression of a constitutively active RhoA construct. The CA-Abl phenotype is not affected by destabilization of microtubules but is reversed partially when actin filaments are stabilized with jasplakinolide. Together, these studies support a critical role for Abl kinases in regulating dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho GTPases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456825      PMCID: PMC6729913          DOI: 10.1523/JNEUROSCI.1264-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

Review 1.  c-Abl in neurodegenerative disease.

Authors:  Sarah D Schlatterer; Christopher M Acker; Peter Davies
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

2.  Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.

Authors:  Amy Friesland; Zhiying Weng; Maria Duenas; Stephen M Massa; Frank M Longo; Qun Lu
Journal:  Neurotoxicology       Date:  2014-09-30       Impact factor: 4.294

3.  Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.

Authors:  Mingchuan Li; Jongdee Nopparat; Byron J Aguilar; Yan-Hua Chen; Jiao Zhang; Jie Du; Xin Ai; Yong Luo; Yongguang Jiang; Christi Boykin; Qun Lu
Journal:  Oncogene       Date:  2020-04-20       Impact factor: 9.867

4.  Synaptic clustering of PSD-95 is regulated by c-Abl through tyrosine phosphorylation.

Authors:  Karen Perez de Arce; Karen Perez de Arce; Lorena Varela-Nallar; Olivia Farias; Alejandra Cifuentes; Paulina Bull; Brian A Couch; Anthony J Koleske; Nibaldo C Inestrosa; Alejandra R Alvarez
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

5.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

Authors:  Sarah E James; Hubert Burden; Russell Burgess; Youmei Xie; Tao Yang; Stephen M Massa; Frank M Longo; Qun Lu
Journal:  Neurotoxicology       Date:  2008-04-26       Impact factor: 4.294

7.  Antidepressant actions of histone deacetylase inhibitors.

Authors:  Herbert E Covington; Ian Maze; Quincey C LaPlant; Vincent F Vialou; Yoshinori N Ohnishi; Olivier Berton; Dan M Fass; William Renthal; Augustus J Rush; Emma Y Wu; Subroto Ghose; Vaishnav Krishnan; Scott J Russo; Carol Tamminga; Stephen J Haggarty; Eric J Nestler
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

8.  Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts.

Authors:  William D Bradley; Anthony J Koleske
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

Review 9.  The trip of the tip: understanding the growth cone machinery.

Authors:  Laura Anne Lowery; David Van Vactor
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-17       Impact factor: 94.444

10.  Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

Authors:  Sarah E James; Mayisha Dunham; Monica Carrion-Jones; Alexander Murashov; Qun Lu
Journal:  Neurotoxicology       Date:  2010-01-08       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.